|
1
|
Cramer DW and Missmer SA: The epidemiology
of endometriosis. Ann N Y Acad Sci. 955:11–22, discussion 34-36,
396-406. 2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Giudice LC: Clinical practice.
Endometriosis. N Engl J Med. 362:2389–2398. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fauconnier A, Staraci S, Huchon C, Roman
H, Panel P and Descamps P: Comparison of patient- and
physician-based descriptions of symptoms of endometriosis: A
qualitative study. Hum Reprod. 28:2686–2694. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Simpson JL, Elias S, Malinak LR and
Buttram VC Jr: Heritable aspects of endometriosis. I. Genetic
studies. Am J Obstet Gynecol. 137:327–331. 1980.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stefansson H, Geirsson RT,
Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, Ingadottir G,
Gulcher J and Stefansson K: Genetic factors contribute to the risk
of developing endometriosis. Hum Reprod. 17:555–559.
2002.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sapkota Y, Steinthorsdottir V, Morris AP,
Fassbender A, Rahmioglu N, De Vivo I, Buring JE, Zhang F, Edwards
TL, Jones S, et al: iPSYCH-SSI-Broad Group: Meta-analysis
identifies five novel loci associated with endometriosis
highlighting key genes involved in hormone metabolism. Nat Commun.
8(15539)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Saha R, Pettersson HJ, Svedberg P,
Olovsson M, Bergqvist A, Marions L, Tornvall P and Kuja-Halkola R:
Heritability of endometriosis. Fertil Steril. 104:947–952.
2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang Z, Zang C, Rosenfeld JA, Schones DE,
Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, et al:
Combinatorial patterns of histone acetylations and methylations in
the human genome. Nat Genet. 40:897–903. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Viganò P, Parazzini F, Somigliana E and
Vercellini P: Endometriosis: Epidemiology and aetiological factors.
Best Pract Res Clin Obstet Gynaecol. 18:177–200. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
McLaren J: Vascular endothelial growth
factor and endometriotic angiogenesis. Hum Reprod Update. 6:45–55.
2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gupta S, Agarwal A, Sekhon L, Krajcir N,
Cocuzza M and Falcone T: Serum and peritoneal abnormalities in
endometriosis: Potential use as diagnostic markers. Minerva
Ginecol. 58:527–551. 2006.PubMed/NCBI
|
|
12
|
Hey-Cunningham AJ, Peters KM, Zevallos HB,
Berbic M, Markham R and Fraser IS: Angiogenesis, lymphangiogenesis
and neurogenesis in endometriosis. Front Biosci (Elite Ed).
5:1033–1056. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Folkman J: Antiangiogenesis in cancer
therapy--endostatin and its mechanisms of action. Exp Cell Res.
312:594–607. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Maruotti N, Cantatore FP, Crivellato E,
Vacca A and Ribatti D: Angiogenesis in rheumatoid arthritis. Histol
Histopathol. 21:557–566. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Smith SK: Angiogenesis, vascular
endothelial growth factor and the endometrium. Hum Reprod Update.
4:509–519. 1998.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rocha AL, Reis FM and Taylor RN:
Angiogenesis and endometriosis. Obstet Gynecol Int.
2013(859619)2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Terman BI, Carrion ME, Kovacs E, Rasmussen
BA, Eddy RL and Shows TB: Identification of a new endothelial cell
growth factor receptor tyrosine kinase. Oncogene. 6:1677–1683.
1991.PubMed/NCBI
|
|
18
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676.
2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sekiguchi K, Ito Y, Hattori K, Inoue T,
Hosono K, Honda M, Numao A, Amano H, Shibuya M, Unno N, et al: VEGF
Receptor 1-Expressing Macrophages Recruited from Bone Marrow
Enhances Angiogenesis in Endometrial Tissues. Sci Rep.
9(7037)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Schlessinger J: Cell signaling by receptor
tyrosine kinases. Cell. 103:211–225. 2000.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ferrara N: Vascular endothelial growth
factor: Basic science and clinical progress. Endocr Rev.
25:581–611. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Holmes K, Roberts OL, Thomas AM and Cross
MJ: Vascular endothelial growth factor receptor-2: Structure,
function, intracellular signalling and therapeutic inhibition. Cell
Signal. 19:2003–2012. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Huang K, Andersson C, Roomans GM, Ito N
and Claesson-Welsh L: Signaling properties of VEGF receptor-1 and
-2 homo- and heterodimers. Int J Biochem Cell Biol. 33:315–324.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Neagoe PE, Lemieux C and Sirois MG:
Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin
synthesis requires the activation of VEGF receptor-1 and -2
heterodimer. J Biol Chem. 280:9904–9912. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Stuttfeld E and Ballmer-Hofer K: Structure
and function of VEGF receptors. IUBMB Life. 61:915–922.
2009.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Fuh G, Li B, Crowley C, Cunningham B and
Wells JA: Requirements for binding and signaling of the kinase
domain receptor for vascular endothelial growth factor. J Biol
Chem. 273:11197–11204. 1998.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lu D, Kussie P, Pytowski B, Persaud K,
Bohlen P, Witte L and Zhu Z: Identification of the residues in the
extracellular region of KDR important for interaction with vascular
endothelial growth factor and neutralizing anti-KDR antibodies. J
Biol Chem. 275:14321–14330. 2000.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wiesmann C, Fuh G, Christinger HW,
Eigenbrot C, Wells JA and de Vos AM: Crystal structure at 1.7 A
resolution of VEGF in complex with domain 2 of the Flt-1 receptor.
Cell. 91:695–704. 1997.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Franklin MC, Navarro EC, Wang Y, Patel S,
Singh P, Zhang Y, Persaud K, Bari A, Griffith H, Shen L, et al: The
structural basis for the function of two anti-VEGF receptor 2
antibodies. Structure. 19:1097–1107. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan
V, Lax I and Schlessinger J: Structural basis for activation of the
receptor tyrosine kinase KIT by stem cell factor. Cell.
130:323–334. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ruch C, Skiniotis G, Steinmetz MO, Walz T
and Ballmer-Hofer K: Structure of a VEGF-VEGF receptor complex
determined by electron microscopy. Nat Struct Mol Biol. 14:249–250.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
32
|
Hvingel B, Lieng M, Roald B and Ørbo A:
Vascular markers CD31, CD34, actin, VEGFB, and VEGFR2, are
prognostic markers for malignant development in benign endometrial
polyps. Open J Obstet Gynecol. 2:18–26. 2012. View Article : Google Scholar
|
|
33
|
Silva LA, Klein C, Ealy AD and Sharp DC:
Conceptus-mediated endometrial vascular changes during early
pregnancy in mares: An anatomic, histomorphometric, and vascular
endothelial growth factor receptor system immunolocalization and
gene expression study. Reproduction. 142:593–603. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Douglas NC, Tang H, Gomez R, Pytowski B,
Hicklin DJ, Sauer CM, Kitajewski J, Sauer MV and Zimmermann RC:
Vascular endothelial growth factor receptor 2 (VEGFR-2) functions
to promote uterine decidual angiogenesis during early pregnancy in
the mouse. Endocrinology. 150:3845–3854. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hall K and Ran S: Regulation of tumor
angiogenesis by the local environment. Front Biosci. 15:195–212.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Wilkinson-Berka JL: Vasoactive factors and
diabetic retinopathy: Vascular endothelial growth factor,
cycoloxygenase-2 and nitric oxide. Curr Pharm Des. 10:3331–3348.
2004.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Dobrzycka B, Kinalski M, Piechocka D and
Terlikowski SJ: The role of estrogens in angiogenesis in the female
reproductive system. Endokrynol Pol. 60:210–214. 2009.(In Polish).
PubMed/NCBI
|
|
38
|
Riccieri V, Stefanantoni K, Vasile M,
Macrì V, Sciarra I, Iannace N, Alessandri C and Valesini G:
Abnormal plasma levels of different angiogenic molecules are
associated with different clinical manifestations in patients with
systemic sclerosis. Clin Exp Rheumatol. 29 (Suppl 65):S46–S52.
2011.PubMed/NCBI
|
|
39
|
Kang S, Shi YY, Li Y, Wang N, Lu YC, Zhou
RM and Zhao XW: Association between genetic variants of the VEGFR-2
gene and the risk of developing endometriosis in Northern Chinese
Women. Gynecol Obstet Invest. 76:32–37. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Vodolazkaia A, Yesilyurt BT, Kyama CM,
Bokor A, Schols D, Huskens D, Meuleman C, Peeraer K, Tomassetti C,
Bossuyt X, et al: Vascular endothelial growth factor pathway in
endometriosis: Genetic variants and plasma biomarkers. Fertil
Steril. 105:988–996. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cardoso JV, Abrão MS, Vianna-Jorge R,
Ferrari R, Berardo PT, Machado DE and Perini JA: Combined effect of
vascular endothelial growth factor and its receptor polymorphisms
in endometriosis: A case-control study. Eur J Obstet Gynecol Reprod
Biol. 209:25–33. 2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
The American Fertility Society: Revised
American Fertility Society classification of endometriosis: 1985.
Fertil Steril 43: 351-352, 1985.
|
|
43
|
Matalliotakis M, Zervou MI, Matalliotaki
C, Rahmioglu N, Koumantakis G, Kalogiannidis I, Prapas I, Zondervan
K, Spandidos DA, Matalliotakis I, et al: The role of gene
polymorphisms in endometriosis. Mol Med Rep. 16:5881–5886.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Leppänen VM, Prota AE, Jeltsch M, Anisimov
A, Kalkkinen N, Strandin T, Lankinen H, Goldman A, Ballmer-Hofer K
and Alitalo K: Structural determinants of growth factor binding and
specificity by VEGF receptor 2. Proc Natl Acad Sci USA.
107:2425–2430. 2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Schrödinger LLC: The PyMOL Molecular
Graphics System 2016 version 2.2. uripymol.org/2/support.htmlsimplepymol.org/2/support.html.
Accessed March 5, 2019.
|
|
46
|
Skol AD, Scott LJ, Abecasis GR and Boehnke
M: Joint analysis is more efficient than replication-based analysis
for two-stage genome-wide association studies. Nat Genet.
38:209–213. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
47
|
Yang Y, Xie P, Opatowsky Y and
Schlessinger J: Direct contacts between extracellular
membrane-proximal domains are required for VEGF receptor activation
and cell signaling. Proc Natl Acad Sci USA. 107:1906–1911.
2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wang Y, Zheng Y, Zhang W, Yu H, Lou K,
Zhang Y, Qin Q, Zhao B, Yang Y and Hui R: Polymorphisms of KDR gene
are associated with coronary heart disease. J Am Coll Cardiol.
50:760–767. 2007.PubMed/NCBI View Article : Google Scholar
|
|
49
|
International HapMap Consortium: The
International HapMap Project. Nature 426: 789-796, 2003.
|
|
50
|
Vazgiourakis V, Zervou MI, Eliopoulos E,
Sharma S, Sidiropoulos P, Franek BS, Myrthianou E, Melissourgaki M,
Niewold T, Boumpas DT, et al: Implication of VEGFR2 in Systemic
Lupus Erythematosus: A structural biological and genetic approach.
Clin Exp Rheumatol. 31:97–102. 2012.PubMed/NCBI
|
|
51
|
Liu Q, Li Y, Zhao J, Sun DL, Duan YN, Wang
N, Zhou RM and Kang S: Association of polymorphisms -1154G/A and
-2578C/A in the vascular endothelial growth factor gene with
decreased risk of endometriosis in Chinese women. Hum Reprod.
24:2660–2666. 2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zhang WL, Sun K, Wang Y, Hu FB and Hui RT:
Abstract 2377: Interaction of the Ile297 variant of vascular
endothelial growth factor receptor-2 gene and homocysteine on the
risk of stroke recurrence. Circulation. 116 (Suppl)(521)2007.
|
|
53
|
Hansen TF, Sørensen FB, Spindler KL, Olsen
DA, Andersen RF, Lindebjerg J, Brandslund I and Jakobsen A:
Microvessel density and the association with single nucleotide
polymorphisms of the vascular endothelial growth factor receptor 2
in patients with colorectal cancer. Virchows Arch. 456:251–260.
2010.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Oh SH, Min KT, Jeon YJ, Kim MH, Moon JS,
Kim HS, Kim WC, Kim OJ, Park EK and Kim NK: Association between
kinase insert domain-containing receptor gene polymorphism and
haplotypes and ischemic stroke. J Neurol Sci. 308:62–66.
2011.PubMed/NCBI View Article : Google Scholar
|
